Please login to the form below

Not currently logged in
Email:
Password:

Intas Pharma

This page shows the latest Intas Pharma news and features for those working in and with pharma, biotech and healthcare.

Teva sells UK and Ireland assets to Intas Pharma for £603m

Teva sells UK and Ireland assets to Intas Pharma for £603m

Under the terms of the deal, a chunk of Actavis' operations in the UK and Ireland will be sold to Accord Healthcare, a subsidiary of Indian generics firm Intas Pharmaceuticals, for ... Accord will claim ownership of a portfolio of generic drugs as well

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    Innocoll (pharma). 209. Capital International. Minority share. Intas (pharma). 106. Bain and others. ... Fingers crossed. Licensing by big pharma. The most common licensing deal is big pharma licensing in from biotech.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...